[Heterologous antistaphylococcal gamma-globulin in the treatment of staphylococcal sepsis].
The first experience with the immunotherapy of staphylococcal sepsis with heterologous anti-staphylococcal gamma-globulin (cozym) with a high antitoxin titer--above 200 A. E./ml--is generalized in the article. The results of the anti-staphylococcal gamma-globulin use in 19 patients are analysed. A comparative evaluation of the drug related to the donor preparation is set forth. The advantages of heterologous anti-staphylococcal gamma-globulin are grounded.
D000328:Adult; D000368:Aged; D000907:Antibodies, Bacterial / Q000032:analysis; D001323:Autoantibodies / Q000032:analysis; D001770:Blood Bactericidal Activity; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000188:drug therapy / Q000276:immunology; D018805:Sepsis / Q000188:drug therapy* / Q000276:immunology; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000276:immunology; D013210:Staphylococcus / Q000276:immunology*; D013997:Time Factors; D005719:gamma-Globulins / Q000627:therapeutic use*
D000907:Antibodies, Bacterial; D001323:Autoantibodies; D005719:gamma-Globulins
Geterologichnyĭ protivostafilokokkovyĭ gamma-globulin v lechenii stafilokokkovogo sepsisa.